NCT05233722View on ClinicalTrials.gov

mTOR as Mediator of Insulin Sensitivity Study

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 10, 2022

Primary Completion Date

June 30, 2029

Study Completion Date

June 30, 2029

Conditions
Insulin Sensitivity
Interventions
OTHER

Exercise

1 hour of one-legged knee-extensor exercise followed by 4 hours of rest

PROCEDURE

Insulin infusion

2 hours of Euglycemic Hyperinsulinemic Clamp

DRUG

Placebo

Administration of 800 mg of calcium tablets

DRUG

Rapamycin

Administration of 16 mg of Rapamycin tablets

Trial Locations (1)

2100

RECRUITING

University of Copenhagen, Copenhagen

All Listed Sponsors
collaborator

Danish Diabetes Academy

OTHER

lead

University of Copenhagen

OTHER